Novartis AG News Headlines

NVS 
$86.56
*  
1.10
 negative 
1.29%
Get NVS Alerts
*Delayed - data as of Apr. 22, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Novartis Q1 Profit Tumbles 18% on Generic Competition, Manufacturing Problems (NVS)
4/24/2012 10:41:35 AM - Dividend.com

Pre-Market Most Active for Apr 16, 2012 : BAC, C, NOK, TOT, NVS, ECYT, SNY, ASML, QQQ, AAPL, ARMH, VOD
4/16/2012 8:39:57 AM - NASDAQ.com News

FDA Clears Cooper Avaira Toric - Analyst Blog
4/12/2012 3:09:45 PM - Zacks.com

Positive Data on Bayer/Onyx Candidate - Analyst Blog
4/10/2012 4:39:01 PM - Zacks.com

Positive Data on Novartis' Glivec - Analyst Blog
4/3/2012 3:19:48 PM - Zacks.com

Cooper Wins an Award - Analyst Blog
4/2/2012 9:19:26 AM - Zacks.com

Neutral on United Therapeutics - Analyst Blog
3/30/2012 7:19:05 PM - Zacks.com

Still Neutral on Human Genome - Analyst Blog
3/30/2012 1:18:43 PM - Zacks.com

Reaffirming Cooper at Neutral - Analyst Blog
3/26/2012 3:15:01 PM - Zacks.com

Incyte Upped to Neutral - Analyst Blog
3/26/2012 10:22:49 AM - Zacks.com

Loss at XOMA Wider Than Expected - Analyst Blog
3/20/2012 10:15:01 AM - Zacks.com

UTHR Files Suit vs. Sandoz - Analyst Blog
3/16/2012 7:21:24 PM - Zacks.com

In Search Of Dividend Growth: Dividend To Free Cash Flow
3/14/2012 9:50:00 AM - Seeking Alpha

Positive Data on Novartis' Signifor - Analyst Blog
3/12/2012 11:22:07 AM - Zacks.com

Cooper Surpasses, Profit Up - Analyst Blog
3/12/2012 9:21:33 AM - Zacks.com

Shire Initiates Trials for Vyvanse - Analyst Blog
3/9/2012 6:20:01 PM - Zacks.com

Novartis' Pipeline Spells Out Strong Growth Potential
3/9/2012 3:48:00 PM - Seeking Alpha

Pfizer Looks Set To Dominate With Takeovers
3/9/2012 3:22:00 PM - Seeking Alpha

Australian Clearance for Eye-Drug Eylea - Analyst Blog
3/9/2012 12:45:01 PM - Zacks.com

Pfizer: 19% Upside Possible This Year
3/8/2012 10:10:00 AM - Seeking Alpha

Tekmira: RNAi Company With Long Term Potential, Short Term Catalysts
3/7/2012 8:13:00 AM - Seeking Alpha

Cell Therapeutics Has Huge Potential To Double Or Triple Soon
3/6/2012 12:42:00 PM - Seeking Alpha

Largest option buying in equities so far
3/6/2012 12:23:35 PM - optionMONSTER

Johnson & Johnson: A High Dividend, Low Risk Stock
3/6/2012 9:30:00 AM - Seeking Alpha

Top Dividend Growth Stocks Ranked By Potency Score For March
3/5/2012 3:26:00 PM - Seeking Alpha